Evaluation of the real time HIV-1, xpert HIV-1, and aptima HIV-1 quant dx assays in comparison to the nucli sens EasyQ HIV-1 v2.0 assay for quantification of HIV-1 viral load

Orna Mor, Yael Gozlan, Marina Wax, Fernando Mileguir, Avia Rakovsky, Bina Noy, Ella Mendelson, Itzchak Levy

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

HIV-1 RNA monitoring, both before and during antiretroviral therapy, is an integral part of HIV management worldwide. Measurements of HIV-1 viral loads are expected to assess the copy numbers of all common HIV-1 subtypes accurately and to be equally sensitive at different viral loads. In this study, we compared for the first time the performance of the NucliSens v2.0, RealTime HIV-1, Aptima HIV-1 Quant Dx, and Xpert HIV-1 viral load assays. Plasma samples (n=404) were selected on the basis of their NucliSens v2.0 viral load results and HIV-1 subtypes. Concordance, linear regression, and Bland-Altman plots were assessed, and mixed-model analysis was utilized to compare the analytical performance of the assays for different HIV-1 subtypes and for low and high HIV-1 copy numbers. Overall, high concordance (>83.89%), high correlation values (Pearson r values of>0.89), and good agreement were observed among all assays, although the Xpert and Aptima assays, which provided the most similar outputs (estimated mean viral loads of 2.67 log copies/ml [95% confidence interval [CI], 2.50 to 2.84 log copies/ml] and 2.68 log copies/ml [95% CI, 2.49 to 2.86 log copies/ml], respectively), correlated best with the RealTime assay (89.8% concordance, with Pearson r values of 0.97 to 0.98). These three assays exhibited greater precision than the NucliSens v2.0 assay. All assays were equally sensitive for subtype B and AG/G samples and for samples with viral loads of 1.60 to 3.00 log copies/ml. The NucliSens v2.0 assay underestimated A1 samples and those with viral loads of>3.00 log copies/ml. The RealTime assay tended to underquantify subtype C (compared to the Xpert and Aptima assays) and subtype A1 samples. The Xpert and Aptima assays were equally efficient for detection of all subtypes and viral loads, which renders these new assays most suitable for clinical HIV laboratories.

Original languageEnglish
Pages (from-to)3458-3465
Number of pages8
JournalJournal of Clinical Microbiology
Volume53
Issue number11
DOIs
StatePublished - Nov 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Fingerprint

Dive into the research topics of 'Evaluation of the real time HIV-1, xpert HIV-1, and aptima HIV-1 quant dx assays in comparison to the nucli sens EasyQ HIV-1 v2.0 assay for quantification of HIV-1 viral load'. Together they form a unique fingerprint.

Cite this